'Kaplan meier' presentation slideshows

Survival Data

Survival Data. John Kornak March 29, 2011 John.kornak@ucsf.edu. Data Analysis Project. You need to complete a data analysis project A 2,000 word write-up is due on 5/20 Presentation sessions on 5/24, 5/26, 5/31 or 6/2 Email me by 4/5 (next Tuesday)

630 views • 51 slides

Main Points to be Covered

Main Points to be Covered. Incidence versus Prevalence The 3 elements of measures of incidence Cumulative vs. person-time incidence Calculating cumulative incidence by the Kaplan-Meier method Calculating cumulative incidence by the life table method. Prevalence versus Incidence.

648 views • 47 slides

Measuring Disease Occurrence

Measuring Disease Occurrence. Occurrence of disease is the fundamental outcome measurement of epidemiology Occurrence of disease is typically a binary (yes/no) outcome Occurrence of disease involves time. Main Points to be Covered. Incidence versus Prevalence

693 views • 42 slides

Logistic Regression & Survival Analysis

Logistic Regression & Survival Analysis. Analysis of binary outcome & time to event data Larry Holmes, Jr Joabyer Hossain. Stats Research, Lecture 7. November 13, 2008. Presentation Objectives. At the end of this presentation, participants should be able to :

430 views • 42 slides

Mining Gene Co-expression Network for Cancer Biomarker Prediction

Mining Gene Co-expression Network for Cancer Biomarker Prediction. Kun Huang Department of Biomedical Informatics OSUCCC Biomedical Informatics Shared Resource. Outline. Introduction Co-expression network for Breast cancer Frequent cancer co-expression network

614 views • 41 slides

Work up of the Asymptomatic Patient with Liver Enzyme Abnormalities

Work up of the Asymptomatic Patient with Liver Enzyme Abnormalities. G.Y. Minuk Professor of Medicine and Pharmacology University of Manitoba Head, Section of Hepatology Health Sciences Centre Winnipeg, Manitoba April 10, 2008. Questions. Does the Patient have Liver Disease?

579 views • 40 slides

Assume the model:

Borgan and Henderson: Event History Methodology Lancaster, September 2006 Session 2: Nelson-Aalen, Kaplan-Meier and Aalen-Johansen estimators. Nelson-Aalen estimator. Assume the model:. at risk indicator. common hazard/intensity (non-negative function).

673 views • 39 slides

Statistics you can use: Practical use of statistics in reading medical research literature

598 views • 39 slides

Part 5: Linking Microarray Data with Survival Analysis

494 views • 38 slides

Part 5: Linking Microarray Data with Survival Analysis

386 views • 38 slides

HSRP 734: Advanced Statistical Methods July 10, 2008

HSRP 734: Advanced Statistical Methods July 10, 2008. Objectives. Describe the Kaplan-Meier estimated survival curve Describe the log-rank test Use SAS to implement. Kaplan-Meier Estimate of Survival Function S(t).

476 views • 27 slides

410 views • 26 slides

Applications of Resampling Methods in Actuarial Practice

Applications of Resampling Methods in Actuarial Practice. by Dr. Richard Derrig Automobile Insurers Bureau of Massachusetts Dr. Krzysztof Ostaszewski Illinois State University Dr. Grzegorz Rempala University of Louisville. CAS Annual Meeting Washington, DC November 12-15, 2000.

246 views • 24 slides

Survival Analysis

Survival Analysis. http://www.isrec.isb-sib.ch/~darlene/EMBnet/. Modeling review. Want to capture important features of the relationship between a (set of) variable(s) and (one or more) responses Many models are of the form g(Y) = f( x ) + error

521 views • 20 slides

Comparison of Two Survival Curves

193 views • 18 slides

Lab 9 Survival Analysis Henian Chen, M.D., Ph.D.

312 views • 17 slides

????????

The Lancet , Volume 376, Issue 9746, Pages 1074 - 1084, 25 September 2010. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. The Lancet ? ????????? ? ??? ? ? The Lancet ??????????????????????????

297 views • 8 slides

Disease specific survival

Disease specific survival. Low SIRT6 nuclear expression. High SIRT6 nuclear expression. P=0.057 (Log-rank test). Supplementary Figure S10.

104 views • 1 slides

Abstract

Weighted Kaplan-Meier Estimator for Adaptive Treatment Strategies in Two-Stage Randomization Designs Sachiko Miyahara, Abdus S. Wahed, Ph.D Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh

119 views • 1 slides

References

Early initiation of continuous renal replacement therapy may be a significant predictor of mortality in acute kidney injury. Abstract Number 33. Department of Internal Medicine, Kosin University College of Medicine Hark Rim, M.D., Ho Sik Shin, M.D. and Yeon Soon Jung M.D. Results.

82 views • 1 slides